Related references
Note: Only part of the references are listed.Causal reasoning on biological networks: interpreting transcriptional changes
Leonid Chindelevitch et al.
BIOINFORMATICS (2012)
Central Role for Interleukin-2 in Type 1 Diabetes
Maigan A. Hulme et al.
DIABETES (2012)
Emerging targets for the treatment of scleroderma
Andrew Leask
EXPERT OPINION ON EMERGING DRUGS (2012)
Inflammation and type one diabetes
David Bending et al.
INTERNATIONAL IMMUNOLOGY (2012)
Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C
M. Motavaf et al.
JOURNAL OF VIRAL HEPATITIS (2012)
KEGG for integration and interpretation of large-scale molecular data sets
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2012)
Prioritizing disease candidate genes by a gene interconnectedness-based approach
Chia-Lang Hsu et al.
BMC GENOMICS (2011)
The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
L. Patrussi et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Immune intervention for type 1 diabetes mellitus
J. S. Skyler
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Trends in the exploitation of novel drug targets
Mathias Rask-Andersen et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Network medicine: a network-based approach to human disease
Albert-Laszlo Barabasi et al.
NATURE REVIEWS GENETICS (2011)
Identifying HIV-1 host cell factors by genome-scale RNAi screening
Lars Pache et al.
METHODS (2011)
The type I interferon system in the etiopathogenesis of autoimmune diseases
Lars Ronnblom
UPSALA JOURNAL OF MEDICAL SCIENCES (2011)
The power of protein interaction networks for associating genes with diseases
Saket Navlakha et al.
BIOINFORMATICS (2010)
Candidate gene prioritization by network analysis of differential expression using machine learning approaches
Daniela Nitsch et al.
BMC BIOINFORMATICS (2010)
The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy
Lars-Gunnar Larsson et al.
EXPERIMENTAL CELL RESEARCH (2010)
DEGAS: De Novo Discovery of Dysregulated Pathways in Human Diseases
Igor Ulitsky et al.
PLOS ONE (2010)
Network-Based Elucidation of Human Disease Similarities Reveals Common Functional Modules Enriched for Pluripotent Drug Targets
Silpa Suthram et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Associating Genes and Protein Complexes with Disease via Network Propagation
Oron Vanunu et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
MYC in Oncogenesis and as a Target for Cancer Therapies
Ami Albihn et al.
ADVANCES IN CANCER RESEARCH, VOL 107 (2010)
Identifying disease-specific genes based on their topological significance in protein networks
Zoltan Dezso et al.
BMC SYSTEMS BIOLOGY (2009)
An empirical framework for binary interactome mapping
Kavitha Venkatesan et al.
NATURE METHODS (2009)
Human Disease-Drug Network Based on Genomic Expression Profiles
Guanghui Hu et al.
PLOS ONE (2009)
Overview of pathogenesis of systemic sclerosis
D. J. Abraham et al.
RHEUMATOLOGY (2009)
Walking the interactome for prioritization of candidate disease genes
Sebastian Koehler et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I
Daniel Kim et al.
ARTHRITIS AND RHEUMATISM (2008)
Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
Jo N. Fleming et al.
PLOS ONE (2008)
Identification of host proteins required for HIV infection through a functional genomic screen
Abraham L. Brass et al.
SCIENCE (2008)
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
Chi-Hwa Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Frontline: ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells
Josef Bodor et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Update on pathophysiology of scleroderma with special reference to immunoinflammatory events
Carlo Chizzolini
ANNALS OF MEDICINE (2007)
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
Sylvie Giuriato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Predicting disease genes using protein-protein interactions
M. Oti et al.
JOURNAL OF MEDICAL GENETICS (2006)
Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes
Lude Franke et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Why do hubs tend to be essential in protein networks?
Xionglei He et al.
PLOS GENETICS (2006)
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
MH Dai et al.
NUCLEIC ACIDS RESEARCH (2005)
Key factors in the rising cost of new drug discovery and development
M Dickson et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Network biology:: Understanding the cell's functional organization
AL Barabási et al.
NATURE REVIEWS GENETICS (2004)
Molecular triangulation: Bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease
M Krauthammer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The MYC Oncogene as a Cancer Drug Target
Heiko Hermeking
CURRENT CANCER DRUG TARGETS (2003)
Sustained loss of a neoplastic phenotype by brief inactivation of MYC
M Jain et al.
SCIENCE (2002)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice
T Tabatabaie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
